EN | ES | DE | FR | IT | 日本語 | 한국어 | 中文

Life Science Playground: IP Roadblocks Faced by Biotech & Pharma Entities

Inc. 5000
In the News: Inc.com Highlights Caldwell IP’s Gratitude Practice
October 14, 2021
MIT eForum: Breakthroughs in Breast Cancer
October 21, 2021

Life Science Playground


Key IP issues pharmaceutical and biotech Entities face as they develop their business strategies

IP issues are among the most challenging and complex considerations that life science and biotech start-ups may face. Recent years have demonstrated record patent filings, assertions of intellectual property rights, and licensing deals created during this exciting and innovative time for the life sciences industry.

We aim to explore the costs, benefit, and role patents and IP may play in biotech start-up development. And, in addition, we will provide guidance on building an IP strategy that supports long-term business objectives and growth.

Come to our playground and mix and mingle with other entrepreneurs and thought leaders in the life sciences sector.

Click here to register

Leave a Reply

Your email address will not be published. Required fields are marked *